Literature DB >> 23405013

ERK-mediated phosphorylation of fibroblast growth factor receptor 1 on Ser777 inhibits signaling.

Malgorzata Zakrzewska1, Ellen Margrethe Haugsten, Beata Nadratowska-Wesolowska, Angela Oppelt, Barbara Hausott, Yixin Jin, Jacek Otlewski, Jørgen Wesche, Antoni Wiedlocha.   

Abstract

Fibroblast growth factor 1 (FGF1) controls cellular activities through the activation of specific cell-surface FGF receptors (FGFRs). Transphosphorylation of tyrosine residues in the kinase domain of FGFRs leads to activation of intracellular signaling cascades, including those mediated by mitogen-activated protein kinases (MAPKs). FGFRs also contain a serine-rich C-terminal tail. We identified a regulatory mechanism of FGFR signaling involving phosphorylation of Ser(777) in the C-terminal region of FGFR1 by the MAPKs extracellular signal-regulated kinase 1 (ERK1) and ERK2. Prevention of the phosphorylation of Ser(777) in FGFR1 or mutation of Ser(777) to alanine enhanced FGF-stimulated receptor tyrosine phosphorylation and increased cell proliferation, cell migration, and axonal growth. A form of FGFR1 with a phosphomimetic mutation at Ser(777) exhibited reduced signaling. Activation of MAPKs by other receptor tyrosine kinases also resulted in phosphorylation of Ser(777) in FGFR1, thereby enabling crosstalk regulation of FGFR activity by other signaling pathways. Our data reveal a negative feedback mechanism that controls FGF signaling and thereby protects the cell from excessive activation of FGFR.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23405013     DOI: 10.1126/scisignal.2003087

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  21 in total

1.  Targeted genetic dependency screen facilitates identification of actionable mutations in FGFR4, MAP3K9, and PAK5 in lung cancer.

Authors:  Shameem Fawdar; Eleanor W Trotter; Yaoyong Li; Natalie L Stephenson; Franziska Hanke; Anna A Marusiak; Zoe C Edwards; Sara Ientile; Bohdan Waszkowycz; Crispin J Miller; John Brognard
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-08       Impact factor: 11.205

2.  The Hypothalamic Arcuate Nucleus-Median Eminence Is a Target for Sustained Diabetes Remission Induced by Fibroblast Growth Factor 1.

Authors:  Jenny M Brown; Jarrad M Scarlett; Miles E Matsen; Hong T Nguyen; Anna Secher; Rasmus Jorgensen; Gregory J Morton; Michael W Schwartz
Journal:  Diabetes       Date:  2019-02-22       Impact factor: 9.461

3.  Divergent effects of intrinsically active MEK variants on developmental Ras signaling.

Authors:  Yogesh Goyal; Granton A Jindal; José L Pelliccia; Kei Yamaya; Eyan Yeung; Alan S Futran; Rebecca D Burdine; Trudi Schüpbach; Stanislav Y Shvartsman
Journal:  Nat Genet       Date:  2017-02-06       Impact factor: 38.330

4.  Dual-specificity phosphatase 5 controls the localized inhibition, propagation, and transforming potential of ERK signaling.

Authors:  Andrew M Kidger; Linda K Rushworth; Julia Stellzig; Jane Davidson; Christopher J Bryant; Cassidy Bayley; Edward Caddye; Tim Rogers; Stephen M Keyse; Christopher J Caunt
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-04       Impact factor: 11.205

5.  MUC18 Differentially Regulates Pro-Inflammatory and Anti-Viral Responses in Human Airway Epithelial Cells.

Authors:  Reena Berman; Chunjian Huang; Di Jiang; James H Finigan; Qun Wu; Hong Wei Chu
Journal:  J Clin Cell Immunol       Date:  2014-10

Review 6.  Fibroblast Growth Factor Signalling in the Diseased Nervous System.

Authors:  Lars Klimaschewski; Peter Claus
Journal:  Mol Neurobiol       Date:  2021-04-15       Impact factor: 5.590

Review 7.  Fibroblast Growth Factor Receptors (FGFRs) and Noncanonical Partners in Cancer Signaling.

Authors:  Harriet R Ferguson; Michael P Smith; Chiara Francavilla
Journal:  Cells       Date:  2021-05-14       Impact factor: 6.600

Review 8.  Negative Regulation of FGFR (Fibroblast Growth Factor Receptor) Signaling.

Authors:  Patrycja Szybowska; Michal Kostas; Jørgen Wesche; Ellen Margrethe Haugsten; Antoni Wiedlocha
Journal:  Cells       Date:  2021-05-28       Impact factor: 6.600

Review 9.  All Good Things Must End: Termination of Receptor Tyrosine Kinase Signal.

Authors:  Azzurra Margiotta
Journal:  Int J Mol Sci       Date:  2021-06-14       Impact factor: 5.923

10.  The KRASG12C Inhibitor MRTX849 Provides Insight toward Therapeutic Susceptibility of KRAS-Mutant Cancers in Mouse Models and Patients.

Authors:  Jill Hallin; Lars D Engstrom; Lauren Hargis; Andrew Calinisan; Ruth Aranda; David M Briere; Niranjan Sudhakar; Vickie Bowcut; Brian R Baer; Joshua A Ballard; Michael R Burkard; Jay B Fell; John P Fischer; Guy P Vigers; Yaohua Xue; Sole Gatto; Julio Fernandez-Banet; Adam Pavlicek; Karen Velastagui; Richard C Chao; Jeremy Barton; Mariaelena Pierobon; Elisa Baldelli; Emanuel F Patricoin; Douglas P Cassidy; Matthew A Marx; Igor I Rybkin; Melissa L Johnson; Sai-Hong Ignatius Ou; Piro Lito; Kyriakos P Papadopoulos; Pasi A Jänne; Peter Olson; James G Christensen
Journal:  Cancer Discov       Date:  2019-10-28       Impact factor: 38.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.